Skip to main content
Caplight Logo









MB Therapeutics

MB Therapeutics

Private
MontpellierHealthcare & Life Scienceshttps://mb-therapeutics.com/en/home/

Momentum

Top 10%

of companies Caplight tracks

Company Overview

MB Therapeutics is a biotechnology company developing a solution for manufacturing personalized medicine through 3D printing for healthcare professionals.

Sector

Healthcare & Life Sciences

Verticals

Medical Devices, 3D Printing, Precision Medicine, Biotech Equipment

Business Model

B2B

Customer Profile

Usage-Based SaaS, Hardware Sales, Services & Consulting

AI Layer

Non-AI

Keywords

pharmaceutical 3D printing3D printed medicinepersonalized medicineon-demand drug manufacturing3D printed pillsprecision medicinepoint-of-care manufacturingautomated compoundingpharmacy automationpharmaceutical 3D printerdecentralized drug manufacturingpersonalized dosageGMP manufacturingdrug shortage solutionpediatric drug deliverypharmaceutical cartridges

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

MB Therapeutics Comparables

Compare MB Therapeutics with similar companies based on industry and business-model similarity.

MB Therapeutics comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Doser
88%
FabRx
88%
CurifyLabs
87%

MB Therapeutics Funding Rounds

Historical fundraising activity

View Full Funding History

Access detailed round history, amounts raised, valuations, and investors.

Key People

Founding team and executive leadership

Stéphane Roulon

CEO & Co-founder - Production Of Personalized Medications Through 3D Printing

Founding Team

Ian Soulairol

Chief Technology Officer

Executive Team

Damien STEFANELLI

Chief Operating Officer

Executive Team

Market signals

Structured signals derived from secondary market and firmographic data.

  • Aug 21, 2026

    Monthly visitors increased 57% MoM.

  • Jul 20, 2026

    Open roles increased to 3, 2.4x the trailing average.

MB Therapeutics Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

MB Therapeutics Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about MB Therapeutics's valuation, stock price, and market status.

Firmographic Details

HeadquartersMontpellier
Employee Range13
Year Founded2023
Last Funding

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?